Paroxetine metabolism is affected by cytochrome P450 (CYP) 2D6 polymorphism

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1468, 2004-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite

The role of cytochrome P450 2D6 in the metabolism of moclobemide

By Hartter S. Dingemanse J. Baier D. Ziegler G. Hiemke C.

European Neuropsychopharmacology, Vol. 6, Iss. 3, 1996-08 ,pp. : 225-230

Elsevier

Access to resources Recommend Favorite

Prediction of Drug Metabolism: The Case of Cytochrome P450 2D6

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 11, 2003-07 ,pp. : 1227-1239

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy

By Ververs F.F. Tessa

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 677-683

Adis International

Access to resources Recommend Favorite

Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans: Use of Paroxetine as a Metabolic Inhibitor Probe

By Segura Mireia Farré Magí Pichini Simona

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 649-660

Adis International

Access to resources Recommend Favorite